AMY REMPE: Open Payments
NPI 1942739131 · HASTINGS, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$184 in 10 payments from 7 companies in 2025. Trend: 2023 $222 · 2024 $177 · 2025 $184
Food & beverage: $184
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
| Gilead Sciences, Inc. | 2 | $35 |
| Grifols USA, LLC | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Lundbeck LLC | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $14 |
Products named: REXULTI, Prolastin-C Liquid, CAPLYTA, Auvelity, Epclusa, MAVYRET.
Industry payments across NE — which companies pay providers there.
